Article
Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.
Journal of viral hepatitis - 1 Oct 2014
Campos-Varela I, Esteban J I, Bes M, Caralt M, Allende H, Rodríguez-Frías F, Salcedo M T, Sauleda S, Charco R, Guardia J, Esteban R, Castells L
Abstract excerpt
The success of current antiviral treatment for hepatitis C virus (HCV) recurrence in liver transplant (LT) recipients remains limited. We aimed at evaluating the value of IL28B genotype and early viral kinetics to predict response to standard treatment in the transplant setting. We retrospectivel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
